Page title
Section title
RXRX Income Statement Key Metrics
- Revenue(TTM)65.18 M
- Gross Profit(TTM)1.96 M
- EBITDA(TTM)-366.27 M
- Net Income(TTM)-377.58 M
- EPS Diluted(TTM)-1.5299999999999998
Decode RXRX's Latest Earnings Call with Ease
Tap 'Generate' for a crystal-clear,
AI-crafted summary and stay ahead in the investment game!
RXRX earnings and revenue history
Gross Profit Margin vs Peers
Profit margin ratio of RXRX (-0.146) is lower than the average of its peers (0.038).
Net Profit Margin vs Peers
Net profit margin ratio of RXRX (-7.360) is lower than the average of its peers (-5.058).
RXRX Return on Equity
See how efficiently RXRX generates profit for it's shareholders.
-70.79%
Poor
Average
Strong
Return on Equity vs Peers
Return on Equity ratio of RXRX (-0.708) is higher than the average of its peers (-0.896).
Return on Equity Growth
RXRX's Return on Equity has shown poor growth over the past 10 years, increasing by only -7.07%.
RXRX Revenue Growth
See how RXRX has grown it's revenue over the past 10 years.
Revenue Growth
RXRX's revenue has grown significantly over the past 10 years, increasing by over 91.94%.
RXRX FY, 2023 Revenue Breakdown
See how RXRX converts it's revenue into profit.
RXRX Balance Sheet Health
RXRX Balance Sheet Breakdown 2023
Assets
Long Term Assets
Cash & Equivalents
Inventory
Receivables
Property Plant Equipments
Others
Liabilities
Short Term Debt
Long Term Debt
Account Payables
Others
RXRX financial position analysis
Short Term Liabilities
RXRX's short term assets($438M) can safely cover it's short term liabilities($93M).
Long Term Liabilities
RXRX's short term assets($438M) can safely cover it's long term liabilities($97M).